Yasuko Tada

Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

S. Dan, D. Sugiyama, K. Hinohara, 2021, Journal for ImmunoTherapy of Cancer.

High Thiobarbiturate-Positive O Antigen of Escherichia coli

Yasuko Tada, Kiyoshi Suzuki, Tadakatu Tazaki, 1971, Infection and immunity.

Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer

M. Tsuboi, K. Goto, G. Ishii, 2020, Science Immunology.

PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Hiromasa Morikawa, S. Sakaguchi, E. Sato, 2019, Proceedings of the National Academy of Sciences.

Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma

A. Kumanogoh, I. Katayama, A. Tanemura, 2018, International immunology.

Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape

M. Tsuboi, S. Ogawa, G. Ishii, 2021, Science Immunology.

Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment

H. Wada, T. Kuwata, T. Doi, 2018, Journal of Immunotherapy for Cancer.